The team at Oxford University behind the landmark RECOVERY trial of COVID-19 therapies now has monkeypox in its sights, with a study that will see if Siga Technologies' smallpox drug Tpoxx can be ...
"This is a desperate ploy from Oxford to gain an upper hand in the most slimy way," said former Cambridge rower Imogen Grant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback